Board Composition
- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- 100-baggers
- Accounting
- Accounting Quality
- Advanced
- anchoring bias
- Asian Paints
- Asset Allocation
- Avenue Supermarts
- balance sheet analysis
- Barbell Strategy
- behavioral finance
- Benjamin Graham
- Board Composition
- Bruce Greenwald
- Business Quality
- Capacity Utilisation
- Capital Allocation
- case study
- cash conversion cycle
- cash flow statement
- Charlie Munger
- chris mayer
- cognitive bias
- compounders
- compounding
- concentrated investing
- conglomerate discount
- core satellite
- corporate actions
- corporate governance
- corporate-governance
- cycle investing
- Dalal Street
- DCF valuation
- debt analysis
- Deferred Tax
- demerger
- dilution
- discounted cash flow
- dividend discount model
- dividend investing
- dividend-history
- dividend-yield
- DMart
- DRHP Analysis
- Earnings Quality
- EBITDA
- enterprise value
- EPV
- EV/EBITDA
- financial analysis
- financial ratios
- Financial Statements
- forensic accounting
- free cash flow
- fundamental analysis
- gordon growth model
- herd mentality
- Howard Marks
- Hurdle Rate
- income statement
- Ind AS 108
- Independent Directors
- independent thinking
- index fund
- Indian Market
- Indian stock market
- Indian Stocks
- Indian Value Investing
- insider-buying
- Interest Coverage Ratio
- intrinsic value
- investing psychology
- investment mistakes
- investment psychology
- investor psychology
- IPO Analysis
- IPO Framework
- IPO Investing
- Kahneman
- Ken Fisher
- long term investing
- long-term investing
- look-through earnings
- loss aversion
- LTCG
- Manish Goel
- margin expansion
- market crash
- market cycles
- market timing
- minority shareholders
- moat
- Mr Market
- Multibagger
- Multibagger Shares
- multibagger stocks
- multibaggershares
- Munger Mental Models
- narrative fallacy
- Nassim Taleb
- Nifty
- Oaktree Capital
- OCF
- operating leverage
- operating profit margin
- operational metrics
- OPM
- Opportunity Cost
- Other Income
- overconfidence bias
- owner-operator
- P/S Ratio
- P&L statement
- payout-ratio
- Peter Lynch
- Philip Fisher
- pledged shares
- portfolio diversification
- portfolio management
- portfolio risk
- portfolio strategy
- preferential allotment
- Price to Sales Ratio
- promoter pledging
- promoter-holding
- prospect theory
- quality investing
- Radhakishan Damani
- Rakesh Jhunjhunwala
- recency bias
- red flags
- reinvestment
- retail investors
- retail sector
- Rights Issues
- Risk Management
- ROCE
- roic
- SEBI
- SEBI Registered
- Segment Reporting
- SENSEX crash
- shareholder-returns
- shareholding-pattern
- Small Cap
- Small Cap Investing
- small caps
- SOTP valuation
- stock analysis
- stock market education
- stock market psychology
- stock picking
- stock valuation
- sunk cost fallacy
- Super Stocks
- survivorship bias
- Switching Costs
- Tax Rate
- tax-loss harvesting
- Titan Biotech
- Titan Biotech case study
- Valuation
- Valuation Methods
- value investing
- value investing course
- value investing India
- value unlocking
- Warren Buffett
- wealth building
- wealth creation
- Working Capital
- working capital efficiency
April 19, 2026
Titan Biotech ended FY25 with an 11-member board, four independent directors, an independent chair, and 14 board meetings - a governance structure that merits serious attention from long-term investors.
